| 40.01 Net Asset Value | +0.65% 1 Day | +23.72% Year-to-Date | Overall Morningstar Rating |
| Health Style or Category | No Load Sales Expenses | 0.99% Expense Ratio | Below Average Morningstar Risk Rating™ |
| 1 month | +3.84% | 3 years | +18.39% | |
| 3 months | +13.66% | 5 years | +13.49% | |
| 1 year | +39.22% | Since inception | +11.95% |
| SHSSX | Category | |
|---|---|---|
| Performance 5-yr return | +13.49% | +12.10% |
| Expense ratio | 0.99% | 1.55% |
| Risk 5 year sharpe ratio | 0.89 | 0.71 |
| Net assets | $2.5B | $1.5B |
| Average market cap | $27.3B | $19.4B |
| Average P/E | 20.6 | 21.6 |
| Portfolio turnover | 135% | 135% |
There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.
| Fund family | BlackRock |
| Fund manager & tenure | Erin Xie / 9 Years |
| Minimal initial investment | $2,000,000.00 |
| Minimum IRA investment | -- |
| Other | 100.00% |
| U.S. stock | -- |
| International stock | -- |
| Fixed income | -- |
| Cash | -- |
| Healthcare | 93.96% |
| Hardware | 3.72% |
| Industrial materials | 1.20% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| PFE Pfizer Inc | 4.87% |
| GILD Gilead Sciences Inc | 4.52% |
| JNJ Johnson & Johnson | 4.27% |
| -- Roche Holding AG | 4.00% |
| CELG Celgene Corporation | 3.88% |
| -- Novartis AG | 3.68% |
| AMGN Amgen Inc | 3.56% |
| BMY Bristol-Myers Squibb Company | 3.29% |
| LLY Eli Lilly and Company | 3.28% |
| -- Sanofi | 2.94% |
.
